MoneyWorks4Me

Morepen Laboratories - Quaterly Results

05 Aug 2026 Evaluate
The sales surged to Rs. 5410.41 millions, up 38.27% for the June 2026 quarter as against Rs. 3912.84 millions during the corresponding quarter previous year.Net Profit witnessed a 569.88% growth almost the double from Rs. 80.61 millions to Rs. 539.99  millions  of same quarter last year.OP of the company witnessed a marginal growth to 849.09 millions from 230.44 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 5410.41 3912.84 38.27 5410.41 3912.84 38.27 16811.95 15545.35 8.15
Other Income 53.11 40.92 29.79 53.11 40.92 29.79 214.95 157.20 36.74
PBIDT 849.09 230.44 268.46 849.09 230.44 268.46 1335.74 1691.31 -21.02
Interest 47.78 38.12 25.34 47.78 38.12 25.34 160.97 71.03 126.62
PBDT 801.31 192.32 316.65 801.31 192.32 316.65 1185.73 1620.28 -26.82
Depreciation 79.79 78.79 1.27 79.79 78.79 1.27 293.08 244.42 19.91
PBT 721.52 113.53 535.53 721.52 113.53 535.53 892.65 1375.86 -35.12
TAX 181.53 32.92 451.43 181.53 32.92 451.43 232.07 360.10 -35.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 84.92 47.27 79.65
PAT 539.99 80.61 569.88 539.99 80.61 569.88 660.58 1015.76 -34.97
Equity 1095.84 1095.84 0.00 1095.84 1095.84 0.00 1095.84 1095.84 0.00
PBIDTM(%) 15.69 5.89 166.48 15.69 5.89 166.48 7.95 10.88 -26.97

Morepen Laboratories Share Price

80.12 0.64 (0.81%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: